🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a clinical trial to evaluate the feasibility and safety of giving t...
Status
Active Not Recruiting
Location
Weill Cornell Medicine/NewYork-Presbyterian Hospital
Start Date
2023-10-04
Trial ID
NCT05934838
Treatments Being Tested
This is a Phase 1/2, open-label, multicenter study to determine the efficac...
Status
Active Not Recruiting
Location
Local Institution - 0006
Start Date
2017-11-27
Trial ID
NCT03331198
The goal of this study is to evaluate the safety and efficacy of CD19 CAR T...
Status
Not Yet Recruiting
Location
Henan Province Engineering Technology Research Center of Immunological Precision Medicine and Artificial Intelligence Application, The Second Affiliated Hospital of Henan University of Science and Technology, Luoyang, China
Start Date
2025-09-30
Trial ID
NCT07161193
Treatments Being Tested
This is an open-label, single-arm, Phase 2 study to evaluate the efficacy a...
Status
Recruiting
Location
The First Hospital of Jilin University
Start Date
2025-12-29
Trial ID
NCT07509086
Treatments Being Tested
This phase I trial studies the side effects and best dose of autologous CD8...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2023-12-15
Trial ID
NCT06043713
This clinical study is to investigate the safety and tolerability of CAR mo...
Status
Terminated
Location
Shanghai Zhongshan Hospital
Start Date
2019-05-16
Trial ID
NCT03960060
Treatments Being Tested
This is a first-in-human dose escalation/dose expansion study to evaluate t...
Status
Active Not Recruiting
Location
H Lee Moffitt Cancer Center and Research Institute
Start Date
2019-05-20
Trial ID
NCT03927261
Treatments Being Tested
Current treatments for relapsed/refractory hematopoietic malignancies such ...
Status
Unknown
Location
Multiple Locations
Start Date
2021-03
Trial ID
NCT04767308
Treatments Being Tested
This is a first-in-human trial proposed to test CD19-specific CAR-T cells w...
Status
Unknown
Location
Xijing Hospital
Start Date
2019-08
Trial ID
NCT04037566
Treatments Being Tested
Chimeric antigen receptor (CAR)-modified T cells can mediate long-term dura...
Status
Unknown
Location
Sanbo Brain Hospital Capital Medical University
Start Date
2016-07
Trial ID
NCT02844062
Treatments Being Tested